NCT02974595
- Conditions
- CANDLE, Chronic Disease, Chronic Inducible Urticaria, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
NLRC4-MAS
Explore clinical trials studying NLRC4-MAS. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
NLRC4-MAS trial results
NCT03113760
- Conditions
- Lymphoproliferative Syndrome, X-Linked, 2, NLRC4-MAS, XIAP Deficiency
- Locations
-
- UCSD _ Department of Pediatrics / Rady Children's Hospital La Jolla, California, United States
- Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States
- Boston Children's Hospital Boston, Massachusetts, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
Completed
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension
NCT03512314
- Conditions
- Lymphoproliferative Syndrome, X-Linked, 2, NLRC4-MAS, XIAP Deficiency
- Locations
-
- UCSD _ Department of Pediatrics / Rady Children's Hospital La Jolla, California, United States
- Shands Children's Hospital Gainsville, Florida, United States
- Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States
- Boston Children's Hospital Boston, Massachusetts, United States